Caphosol® Artifical Saliva (32 doses sachet box)— 510(k) K234015

Substantially Equivalent

Eusa Pharma (Uk) Limited

FDA 510(k) clearance K234015 for Caphosol® Artifical Saliva (32 doses sachet box), Substantially Equivalent on 2024-03-11. Applicant: Eusa Pharma (Uk) Limited. Device class: Unclassified.

Clearance details

Applicant
Eusa Pharma (Uk) Limited
Product code
Code LFD
Device class
Unclassified
Advisory panel
Unknown
Date received
Decision date
Decision
Substantially Equivalent
Clearance type
Traditional
Location
Hemel Hempstead, GB
Download summary PDFView on FDA.gov ↗

Recent devices under product code LFD

view all

More clearances from Eusa Pharma (Uk) Limited

view all

Adverse events under product code LFD

product code LFD
Death
3
Total
3

Source: openFDA MAUDE database, through . Counts aggregate all devices under this product code, not just this specific clearance. Reports are submissions to FDA, not validated events. Search MAUDE directly →

Recalls naming K234015

K-number listed on FDA's recall record

Matched by K-number from FDA's Recall Enterprise System record (openFDA device/recallk_numbers) — these recalls explicitly list K234015.

Data sourced from openFDA. This site is unofficial and independent of the FDA.